These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23071500)

  • 1. High N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction.
    Lorgis L; Moreau D; Mock L; Daumas B; Potard D; Touzery C; Cottin Y; Zeller M
    PLoS One; 2012; 7(10):e44677. PubMed ID: 23071500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Pro-B-Type Natriuretic Peptide Levels Inversely Correlated With Heart Rate Variability in Patients With Unstable Angina Pectoris.
    Dufang M; Yongcheng W; Ping J; Yonghui Y; Xiao L
    Int Heart J; 2016 May; 57(3):292-8. PubMed ID: 27170473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease].
    Chen TT; Shi K; Liu YL; Guo YH; Li Y; Wang XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in autonomic control of heart rate after ischemic cerebral stroke].
    Lakusić N; Mahović D; Babić T; Sporis D
    Acta Med Croatica; 2003; 57(4):269-73. PubMed ID: 14639860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-wave alternans and heart rate variability: a comparison in patients with myocardial infarction with or without diabetes mellitus.
    Ren L; Fang X; Wang Y; Qi G
    Ann Noninvasive Electrocardiol; 2011 Jul; 16(3):232-8. PubMed ID: 21762250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cigarette smoking on heart rate variability and plasma N-terminal pro-B-type natriuretic peptide in healthy subjects: is there the relationship between both markers?
    Alyan O; Kacmaz F; Ozdemir O; Maden O; Topaloglu S; Ozbakir C; Metin F; Karadede A; Ilkay E
    Ann Noninvasive Electrocardiol; 2008 Apr; 13(2):137-44. PubMed ID: 18426439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of cardiovascular rehabilitation on the variability of the RR cycle after a first uncomplicated acute myocardial infarct].
    Carunchio A; Fera MS; Bordi L; Daniele R; Rulli F; Coletta C; Burattini M; Greco G; Martinelli MM; Porzio A; Lumia F; Ceci V
    Ital Heart J Suppl; 2000 Feb; 1(2):241-9. PubMed ID: 10731382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
    Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
    Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do collaterals affect heart rate variability in patients with acute myocardial infarction?
    Ozdemr O; Soylu M; Demr AD; Geyk B; Alyan O; Chan G; Topaloglu S; Aras D; Balbay Y; Sasmaz H
    Coron Artery Dis; 2004 Nov; 15(7):405-11. PubMed ID: 15492589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.
    McKie PM; Cataliotti A; Sangaralingham SJ; Ichiki T; Cannone V; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
    Mayo Clin Proc; 2011 Dec; 86(12):1154-60. PubMed ID: 22134933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cross-sectional study of relation between blood pressure and heart rate variability in patients with peritoneal dialysis].
    Li LX; Tang W; Chen BJ; Wang T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):849-54. PubMed ID: 22178833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of pro-B-type natriuretic peptide levels with heart rate variability in diabetic patients].
    Lin H; Chen XH; Wu ZH; Zhang DH; Chen XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):146-8. PubMed ID: 25613632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
    McKelvie RS; Komajda M; McMurray J; Zile M; Ptaszynska A; Donovan M; Carson P; Massie BM;
    J Card Fail; 2010 Feb; 16(2):128-34. PubMed ID: 20142024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.